Previous Article | Next Article ![]()
Journal of Virology, January 2001, p. 396-407, Vol. 75, No. 1
Laboratory of Molecular Microbiology,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, Maryland 20892,1
and Life Sciences Division, Lawrence Berkeley National
Laboratory, Berkeley, California 947202
Received 30 June 2000/Accepted 22 September 2000
Recent evidence from several investigators suggest that the human
T-cell leukemia virus type 1 Tax oncoprotein represses the transcriptional activity of the tumor suppressor protein, p53. An
examination of published findings reveals serious controversy as to the
mechanism(s) utilized by Tax to inhibit p53 activity and whether the
same mechanism is used by Tax in adherent and suspension cells. Here,
we have investigated Tax-p53 interaction simultaneously in adherent
epithelial (HeLa and Saos) and suspension T-lymphocyte (Jurkat) cells.
Our results indicate that Tax activity through the CREB/CREB-binding
protein (CBP), but not NF-
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.1.396-407.2001
Genetic Evidence of a Role for ATM in Functional
Interaction between Human T-Cell Leukemia Virus Type 1 Tax and
p53
B, pathway is needed to repress the
transcriptional activity of p53 in all tested cell lines. However, we
did find that while CBP binding by Tax is necessary, it is not
sufficient for inhibiting p53 function. Based on knockout cell studies,
we correlated a strong genetic requirement for the ATM, but not protein
kinase-dependent DNA, protein in conferring a Tax-p53-repressive phenotype.
*
Corresponding author. Mailing address: LMM, NIAID, NIH,
Building 4, Room 306, 9000 Rockville Pike, Bethesda, MD 20892-0460. Phone: (301) 496-6680. Fax: (301) 480-3686. E-mail:
kj7e{at}nih.gov.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|